Anaplastic Oligoastrocytoma – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Anaplastic oligoastrocytoma is a type of brain tumor that forms when two types of glial cells, called oligodendrocytes and astrocytes, rapidly increase in number to create a mass in the cerebrum. It is classified as a WHO Grade-III tumor and is the third most common primary brain tumor, comprising about 5-10% of all gliomas. Some anaplastic oligoastrocytomas may contain aggressive glioblastoma cells, which are grade IV. The tumor is considered anaplastic when it grows quickly, and the cancer cells have the potential to spread to surrounding brain tissue or other parts of the body. The cause of this condition is unknown, and it is typically diagnosed in adults between 30 and 50. Anaplastic oligoastrocytoma may present seizures but is more likely to present with acute to subacute onset of neurologic symptoms such as headache, focal weakness, vision changes, or congestive deficits due to mass effect from the tumor. Anaplastic oligodendrogliomas are extremely rare in the USA, wi